The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Acd-A
Anticoagulant Citrate Dextrose Solution Formula A · DEXTROSE MONOHYDRATE 24.5 g/1000mL; SODIUM CITRATE, UNSPECIFIED FORM 22 g/1000mL; ANHYDROUS CITRIC ACID 7.3 g/1000mL · Solution · Intravenous · Fenwal, Inc.
NDC 00942-0641-04 · 1000 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Baxter Healthcare CorporationUnited Statesmanufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- BN160918
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Anticoagulant Citrate Dextrose Solution Formula A (Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 12.25 g/500mL; SODIUM CITRATE, UNSPECIFIED FORM 11 g/500mL; ANHYDROUS CITRIC ACID 3.65 g/500mL | Aug 26, 2026 | Sep 2, 2026 |
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 24.5 g/1000mL; SODIUM CITRATE, UNSPECIFIED FORM 22 g/1000mL; ANHYDROUS CITRIC ACID 7.3 g/1000mL | Aug 26, 2026 | Sep 2, 2026 |
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 3.65 g/500mL; SODIUM CITRATE, UNSPECIFIED FORM 12.25 g/500mL; ANHYDROUS CITRIC ACID 11 g/500mL | Jul 22, 2026 | Aug 19, 2026 |
| Fenwal, Inc. | DEXTROSE MONOHYDRATE 7.3 g/1000mL; SODIUM CITRATE, UNSPECIFIED FORM 24.5 g/1000mL; ANHYDROUS CITRIC ACID 22 g/1000mL | Jul 22, 2026 | Aug 19, 2026 |
| Fenwal, Inc. | ANHYDROUS CITRIC ACID 3.65 g/500mL; DEXTROSE MONOHYDRATE 12.25 g/500mL; SODIUM CITRATE, UNSPECIFIED FORM 11 g/500mL | Jul 15, 2026 | Jul 15, 2026 |
| Fenwal, Inc. | ANHYDROUS CITRIC ACID 7.3 g/1000mL; DEXTROSE MONOHYDRATE 24.5 g/1000mL; SODIUM CITRATE, UNSPECIFIED FORM 22 g/1000mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Acd-A — NDC 00942-0641-04," retrieved September 3, 2026, https://drugdashboards.com/drug/00942064104.
Free to cite with attribution — see how the data is put together.